{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:40:10Z","timestamp":1772707210637,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":1514,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s13311-019-00726-3","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T12:03:35Z","timestamp":1553601815000},"page":"784-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Magali","family":"Cabanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Pistono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Puygrenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyangana","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Jeantet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Garret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1007\/s13311-019-00726-3_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes\/","volume":"72","author":"The Huntington's disease collaborative research group","year":"1993","journal-title":"Cell."},{"key":"10.1007\/s13311-019-00726-3_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience."},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch Neurol."},{"issue":"5","key":"10.1007\/s13311-019-00726-3_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2010.02.009","article-title":"Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease","volume":"16","author":"Aziz","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11910-010-0163-x","article-title":"Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease","volume":"11","author":"Goodman","year":"2011","journal-title":"Curr Neurol Neurosci Rep."},{"key":"10.1007\/s13311-019-00726-3_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.expneurol.2012.10.014","article-title":"Circadian and sleep disorder in Huntington's disease","volume":"243","author":"Morton","year":"2013","journal-title":"Exp Neurol."},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease","volume":"25","author":"Morton","year":"2005","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience."},{"issue":"Pt 7","key":"10.1007\/s13311-019-00726-3_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/brain\/awt128","article-title":"Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation","volume":"136","author":"Kantor","year":"2013","journal-title":"Brain : a journal of neurology."},{"issue":"Pt 7","key":"10.1007\/s13311-019-00726-3_bib9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/awt132","article-title":"Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington's disease","volume":"136","author":"Fisher","year":"2013","journal-title":"Brain : a journal of neurology."},{"issue":"5","key":"10.1007\/s13311-019-00726-3_bib10","doi-asserted-by":"crossref","first-page":"e0126972","DOI":"10.1371\/journal.pone.0126972","article-title":"Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6\/1 Huntington's Disease Mice","volume":"10","author":"Lebreton","year":"2015","journal-title":"PloS one."},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp Neurol."},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5665\/sleep.5448","article-title":"Quantitative electroencephalographic analysis provides an early-stage indicator of disease onset and progression in the zQ175 knock-in mouse model of Huntington's disease","volume":"39","author":"Fisher","year":"2016","journal-title":"Sleep"},{"issue":"7","key":"10.1007\/s13311-019-00726-3_bib13","doi-asserted-by":"crossref","first-page":"e69993","DOI":"10.1371\/journal.pone.0069993","article-title":"The Q175 mouse model of Huntington's disease shown gene dosage- and age-related decline in circadian rhythms of activity and sleep","volume":"8","author":"Loh","year":"2013","journal-title":"PloS One."},{"issue":"11","key":"10.1007\/s13311-019-00726-3_bib14","doi-asserted-by":"crossref","first-page":"e79509","DOI":"10.1371\/journal.pone.0079509","article-title":"beta oscillation during slow wave sleep and rapid eye movement sleep in the electroencephalogram of a transgenic mouse model of Huntington's disease","volume":"8","author":"Jeantet","year":"2013","journal-title":"PloS One"},{"issue":"5","key":"10.1007\/s13311-019-00726-3_bib15","doi-asserted-by":"crossref","first-page":"e19965","DOI":"10.1371\/journal.pone.0019965","article-title":"Sex-dependent changes in social behaviors in motor pre-symptomatic R6\/1 mice","volume":"6","author":"Pietropaolo","year":"2011","journal-title":"PloS one"},{"key":"10.1007\/s13311-019-00726-3_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroscience.2016.05.027","article-title":"Early GABAergic transmission defects in the external globus pallidus and rest\/activity rhythm alteration in a mouse model of Huntington's disease","volume":"329","author":"Du","year":"2016","journal-title":"Neuroscience"},{"issue":"29","key":"10.1007\/s13311-019-00726-3_bib17","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","article-title":"Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease","volume":"27","author":"Pallier","year":"2007","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience."},{"key":"10.1007\/s13311-019-00726-3_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","article-title":"Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease","volume":"1279","author":"Pallier","year":"2009","journal-title":"Brain research."},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","article-title":"A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease","volume":"21","author":"Morton","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00726-3_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.344","article-title":"Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.","volume":"5","author":"Whittaker","year":"2017","journal-title":"Pharmacological research and perspective."},{"key":"10.1007\/s13311-019-00726-3_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2013.11.008","article-title":"Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease","volume":"63","author":"Cuesta","year":"2014","journal-title":"Neurobiology of disease"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2011.07.016","article-title":"The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease","volume":"45","author":"Cuesta","year":"2012","journal-title":"Neurobiology of disease"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib23","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0431-17.2017","article-title":"Time-restricted feeding improves circadian dysfunction as well as motor symptoms in the Q175 mouse model of Huntington's disease.","volume":"5","author":"Wang","year":"2017","journal-title":"eNeuro."},{"key":"10.1007\/s13311-019-00726-3_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbscr.2016.12.002","article-title":"Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse modeld of Huntington's disease","volume":"2","author":"Wang","year":"2017","journal-title":"Neurobiology of sleep and circadian rhythms"},{"issue":"10","key":"10.1007\/s13311-019-00726-3_bib25","doi-asserted-by":"crossref","first-page":"e47026","DOI":"10.1371\/journal.pone.0047026","article-title":"Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington's disease","volume":"7","author":"Hong","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nature Reviews Neuroscience"},{"issue":"7168","key":"10.1007\/s13311-019-00726-3_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature06310","article-title":"Neural substrates of awakening probed with optogenetic control of hypocretin neurons","volume":"450","author":"Adamantidis","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1460-9568.2010.07295.x","article-title":"GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep","volume":"32","author":"Hassani","year":"2010","journal-title":"European Journal of Neuroscience"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jchemneu.2007.10.002","article-title":"Melanin-concentrating hormone projections to areas involved in somatomotor responses","volume":"35","author":"Elias","year":"2008","journal-title":"Journal of chemical neuroanatomy"},{"issue":"6","key":"10.1007\/s13311-019-00726-3_bib31","doi-asserted-by":"crossref","first-page":"zsy068","DOI":"10.1093\/sleep\/zsy068","article-title":"Melanin-concentrating hormone-expressing neurons adjust slow-wave sleep dynamics to catalyze paradoxical (REM) sleep","volume":"41","author":"Varin","year":"2018","journal-title":"Sleep"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"Suppl 3","key":"10.1007\/s13311-019-00726-3_bib33","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/S1353-8020(08)70035-X","article-title":"Hypocretin-1 and secondary signs in Huntington's disease","volume":"13","author":"Roos","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-0004.2006.00636.x","article-title":"Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington's disease","volume":"70","author":"Bj\u00f6rkqvist","year":"2006","journal-title":"Clinical Genetics"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2005.09.028","article-title":"Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease","volume":"1063","author":"Meier","year":"2005","journal-title":"Brain Research"},{"issue":"9","key":"10.1007\/s13311-019-00726-3_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s00415-006-0146-7","article-title":"Hypocretin-1 (orexin A) levels are normal in Huntington's disease","volume":"253","author":"Baumann","year":"2006","journal-title":"Journal of neurology"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.02.006","article-title":"Paradoxical function of orexin\/hypocretin circuits in a mouse model of Huntington's disease","volume":"42","author":"Williams","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00726-3_bib38","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.2147\/DDDT.S73224","article-title":"Profile of suvorexant in the management of insomnia","volume":"9","author":"Sutton","year":"2015","journal-title":"Drug design, development and therapy"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-0270(03)00172-9","article-title":"Design of a twin tetrode microdrive and headstage for hippocampal single unit recordings in behaving mice","volume":"129","author":"Jeantet","year":"2003","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1007\/s13311-019-00726-3_bib41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0013-4694(78)90290-0","article-title":"Origin of the neocortically monitored theta rhythm in the curarized rat","volume":"45","author":"Gerbrandt","year":"1978","journal-title":"Electroencephalography and clinical neurophysiology"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nature Protocol"},{"issue":"7","key":"10.1007\/s13311-019-00726-3_bib43","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1073\/pnas.0811400106","article-title":"Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle","volume":"106","author":"Hassani","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/(SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.0.CO;2-S","article-title":"Hypocretin\/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems","volume":"402","author":"Broberger","year":"1998","journal-title":"Journal of Comparative Neurolology"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1471-4159.2004.02776.x","article-title":"Characterization of subpopulations of neurons producing melanin-concentrating hormone in the rat ventral diencephalon","volume":"91","author":"Cvetkovic","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1007\/s13311-019-00726-3_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2202-4-19","article-title":"A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep","volume":"4","author":"Verret","year":"2003","journal-title":"BMC neuroscience"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1007\/s13311-019-00726-3_bib48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Related Disorders"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib50","doi-asserted-by":"crossref","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease","volume":"11","author":"Kuljis","year":"2016","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00726-3_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2016.01.027","article-title":"A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease mice","volume":"105","author":"Kantor","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s13311-017-0546-7","article-title":"Chronic Paroxetine treatment prevents the emergence of abnormal electroencephalogram oscillations in Huntington's disease mice","volume":"14","author":"Kantor","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1007\/s13311-019-00726-3_bib53","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/npp.2013.139","article-title":"Quantitative electroencephalography within sleep\/wake states differentiates GABA A modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats","volume":"38","author":"Fox","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1007\/s13311-019-00726-3_bib54","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.5665\/sleep.4068","article-title":"Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects","volume":"37","author":"Ma","year":"2014","journal-title":"Sleep"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease","volume":"25","author":"Morton","year":"2005","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"12","key":"10.1007\/s13311-019-00726-3_bib56","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/jnr.24320","article-title":"Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease","volume":"96","author":"Kuljis","year":"2018","journal-title":"J Neurosci Res"},{"issue":"8","key":"10.1007\/s13311-019-00726-3_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tips.2011.03.007","article-title":"Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostatis and arousal","volume":"32","author":"Sakurai","year":"2011","journal-title":"Trends in Pharmacological sciences"},{"issue":"11","key":"10.1007\/s13311-019-00726-3_bib58","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn3837","article-title":"The role of orexin in motivated behaviours","volume":"15","author":"Sakurai","year":"2014","journal-title":"Nature Reviews Neuroscience"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"issue":"5","key":"10.1007\/s13311-019-00726-3_bib60","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jnc.12840","article-title":"Gender differences between hypocretin\/orexin knockout and wild type mice: age, body weight, body composition, metabolic markers, leptin and insulin resistance","volume":"131","author":"Ramanathan","year":"2014","journal-title":"J Neurochem"},{"issue":"8","key":"10.1007\/s13311-019-00726-3_bib61","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/endo.142.8.8299","article-title":"Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats","volume":"142","author":"J\u00f6hren","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"10.1007\/s13311-019-00726-3_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2009.07.035","article-title":"Sex differences in the responses of orexin neurons in the lateral hypothalamic area and feeding behavior to fasting","volume":"463","author":"Funabashi","year":"2009","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1007\/s13311-019-00726-3_bib63","first-page":"137","article-title":"Fos expression in hypocretinergic neurons in C57B1\/6 male and female mice after long-term consumption of high fat diet","volume":"42","author":"Pirnik","year":"2008","journal-title":"Endocr Regul"},{"issue":"8","key":"10.1007\/s13311-019-00726-3_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmg.28.8.515","article-title":"Age at onset in Huntington's disease: effect of line of inheritance and patients's sex","volume":"28","author":"Roos","year":"1991","journal-title":"Journal of medical genetics"},{"issue":"2","key":"10.1007\/s13311-019-00726-3_bib65","doi-asserted-by":"crossref","first-page":"RC202","DOI":"10.1523\/JNEUROSCI.22-02-j0006.2002","article-title":"Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene","volume":"22","author":"Rebec","year":"2002","journal-title":"Journal of neuroscience"},{"issue":"10","key":"10.1007\/s13311-019-00726-3_bib66","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbagen.2009.11.013","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"1800","author":"Simpkins","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"10.1007\/s13311-019-00726-3_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijdevneu.2015.07.005","article-title":"Developmental changes in the hypothalamic mRNA levels of prepro-orexin and orexin receptors and their sensitivity to fasting in male and female rats","volume":"46","author":"Iwasa","year":"2015","journal-title":"Int J Dev Neurosci"},{"issue":"6","key":"10.1007\/s13311-019-00726-3_bib68","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0196-9781(02)00052-9","article-title":"Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus","volume":"23","author":"Johren","year":"2002","journal-title":"Peptides"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00726-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:15:22Z","timestamp":1761808522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923018202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1878747923018202"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00726-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00726-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}